Nicole R. Hadas

Companies

• Akebia Therapeutics, Inc.General counsel Aug 5, 2014 to May 14, 2024¹
• Akebia Therapeutics, Inc.Officer Mar 19, 2014 to Mar 27, 2014²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkebia Therapeutics, Inc. AKBA651,243 shares³$459.7K at $0.71May 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 13, 2024Sold 12,016 shares at $1.26 of Akebia Therapeutics, Inc.³
• Feb 29, 2024Sold 5,974 shares at $1.58 of Akebia Therapeutics, Inc.⁴
• Feb 27, 2024Sold 7,411 shares at $1.52 of Akebia Therapeutics, Inc.⁵
• Jan 31, 2024Granted 149,300 shares of Akebia Therapeutics, Inc.⁶
• May 25, 2023Sold 63,186 shares at $1.22 of Akebia Therapeutics, Inc.⁷
• May 24, 2023Granted 200,000 shares of Akebia Therapeutics, Inc.⁷
• May 12, 2023Granted 100,000 shares of Akebia Therapeutics, Inc.⁸
• Mar 1, 2023Sold 1,088 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Mar 1, 2023Sold 6,613 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Mar 1, 2023Sold 5,333 shares at $0.88 of Akebia Therapeutics, Inc.⁹
• Feb 27, 2023Sold 6,677 shares at $0.81 of Akebia Therapeutics, Inc.¹⁰
• Mar 1, 2022Sold 1,078 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Mar 1, 2022Sold 6,556 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Mar 1, 2022Sold 6,873 shares at $2.17 of Akebia Therapeutics, Inc.¹¹
• Feb 28, 2022Granted 50,000 shares of Akebia Therapeutics, Inc.¹¹
• Feb 28, 2022Sold 6,555 shares at $2.15 of Akebia Therapeutics, Inc.¹¹